Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.8%

2 terminated out of 42 trials

Success Rate

88.9%

+2.3% vs benchmark

Late-Stage Pipeline

14%

6 trials in Phase 3/4

Results Transparency

19%

3 of 16 completed with results

Key Signals

3 with results89% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (22)
Early P 1 (1)
P 1 (3)
P 2 (4)
P 3 (2)
P 4 (4)

Trial Status

Completed16
Unknown7
Not Yet Recruiting7
Recruiting7
Terminated2
Withdrawn2

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (42)

Showing 20 of 20 trials
NCT03258658Phase 1Recruiting

Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures

NCT07676942Not ApplicableNot Yet RecruitingPrimary

Intraoperative Lidocaine or Dexmedetomidine for Postoperative Pain Modulation After Urethral Reconstruction.

NCT07668973Not ApplicableNot Yet RecruitingPrimary

Comparison Between Excision And Primary Anastomosis Urethroplasty And Tunica Vaginalis Graft Urethroplasty.

NCT03499964Not ApplicableActive Not RecruitingPrimary

ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

NCT05463991Not ApplicableCompletedPrimary

Bioengineered Collagen Implant for Urethral Stricture Repair

NCT05383274Phase 4RecruitingPrimary

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

NCT07508566Not ApplicableNot Yet RecruitingPrimary

A Comparative Study of the Antibacterial Effects of Two Preoperative Hair Removal Methods in Male Patients With Urethral Stricture

NCT07501884Phase 4Not Yet RecruitingPrimary

REDUCER Trial (TXA in Urethroplasty)

NCT07403786Not Yet RecruitingPrimary

Urethral Resistive Index (URI): A New Parameter for Diagnosing Urethral Obstruction

NCT07375641Not Yet RecruitingPrimary

The Impact of Age and Sex on Anticipated and Experienced Pain in First-Time Outpatient Flexible Cystoscopy

NCT06795074Phase 4RecruitingPrimary

Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon

NCT03270384Not ApplicableCompletedPrimary

Re-establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

NCT07074717Not ApplicableRecruiting

Penile Skin Versus Buccal Mucosal Graft in Augmentation Urethroplasty for Long Anterior Urethral Stricture

NCT06827210Not ApplicableNot Yet RecruitingPrimary

Treatment of Bulbar Urethral Strictures With Optilume Drug-Coated Balloons in an Untreated Population

NCT06064968Not ApplicableCompletedPrimary

Effectiveness of Intermittent Bladder Catheterization (IBC) in Reducing Recurrence of Urethral Stricture

NCT06384066Not ApplicableWithdrawnPrimary

Mobile Health Application to Improve Patient Satisfaction After Urethroplasty

NCT04965025Not ApplicableRecruiting

Multi-stage Urethroplasty with Augmentation Using a Dorsal Graft Inlay Technique Comparing Graft Use in First or Second Stage

NCT03859024Phase 4Completed

Efficacy of Opioid-limiting Pain Management Protocol in Men Undergoing Urethroplasty

NCT06362083RecruitingPrimary

Urethral Stricture Database

NCT06232005Phase 2CompletedPrimary

Intralesional Injection of Mitomycin C Following Visual Internal Urethrotomy for Recurrent Urethral Stricture

Scroll to load more

Research Network

Activity Timeline